Omnicell (NASDAQ: OMCL) reported Q1 EPS of $0.66, $0.13 better than the analyst estimate of $0.53. Revenue for the quarter came in at $229.7 million versus the consensus estimate of $219.41 million.

“Our mission to be a trusted partner for our customers has never been more critical,” said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell. “Our teams have mobilized to quickly deliver the solutions and intelligence needed to support critical care needs, while protecting the health and safety of our customers and employees, and maintaining business continuity.”

For earnings history and earnings-related data on Omnicell (OMCL) click here.